Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

View source ↗

Summary

Clinical trial update describing training for Louisiana pharmacists to implement PrEP prescribing and establish an active PrEP prescribing surveillance program;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Descovy (emtricitabine/tenofovir alafenamide)
  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Xavier University of Louisiana. | Conditions: HIV Prevention | Status: NOT_YET_RECRUITING